BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Element Genomics is defunct.

Fate: Acquired by UCB, April 2018, up to $30M


------------------
If you believe any of this information is incorrect, please let us know.